Brain Injuries, Stroke
Conditions
Keywords
brain protection, cardiac surgery, heart valve replacement, electroacupuncture, pretreatment, preconditioning, Thoracic Surgery
Brief summary
The purpose of this study is to evaluate the neuroprotective effect of electroacupuncture pretreatment in patients undergoing cardiac surgery as an preventive sequela in a randomized and controlled clinical trial. In addition, to investigate the role of inflammatory responses in the precess of the protection.
Detailed description
Heart valve replacement surgery has been proved to be an effective method in treating both regenerative and rheumatic valve disease. Current studies showed that cardiopulmonary bypass (CPB) and operation related cerebral injury is associated with worse patient morbidity and mortality after elective valve replacement surgery. Recently, Electroacupuncture (EA) pretreatment was proved to produced cerebral protective effects by mimicking ischemic preconditioning in animal models. However, the evidence that EA pretreatment can improve the clinical outcomes such as mortality and morbidity, is still lacking. The investigators perform a randomized controlled study to evaluate that EA pretreatment can improve the outcomes of cardiac surgery. Purpose: The purpose of this study is to examine if EA pretreatment can decrease the mortality and postoperative cerebrovascular complications in patients undergoing cardiac surgery. The effect will be assessed by mortality, scores of neurological defect, post operative cognitive dysfunction and stroke. Methods: Study patients will be randomized to cardiac surgery with EA pretreatment or conventional cardiac surgery in the Department of cardiovascular surgery, Xijing Hospital. EA pretreatment is performed at Baihui acupoint 30 min per day 5 consecutive days before the heart valve replacement surgery．Primary study outcome is cerebrovascular complications within 6 postoperative months. Secondary outcomes include the S-100B and NSE blood level measured during the first 72 hours of surgery follow-up, the several cytokines, including TNF-a, IL-8, IL-6, IL-10 and HMGB-1 blood level measured during the first 7 days of surgery follow-up, all cardiovascular haemodynamic parameters as measured by a pulmonary artery catheter, the length of intensive care unit (ICU) stay and length of postoperative hospital stay.
Interventions
PROCEDUREnon electroacupuncture stimulation
The same procedure as electroacupuncture except stimulation
PROCEDUREElectroacupuncture pretreatment
According to the theory of traditional Chinese medicine, Baihui(GV20) acupoint was chosen and the acupuncture points were identified according to traditional anatomical localization. Once insertion was made at the acupuncture point, the needle was stimulated electrically with the intensity of 0.8-1.9 mA and frequency of 5/30 Hz for 30 min per day using an Electronic Acupuncture Treatment Instrument for 5 consecutive days before the heart valve replacement surgery．
Sponsors
Air Force Military Medical University, China
Xijing Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
This study enrolls a group of 40-65years patients who have heart valve disease who need valve replacement. Inclusion Criteria: * patients who have the indication for aortic or mitral valve replacement * patients would like to accept the follow-up and sign the informed consent * patients with heart function of NYHA I-III degree.
Exclusion criteria
* pregnant or nursing women * comorbid with coronary artery disease * patients with heart function of NYHA IV degree * renal dysfunction with serum creatinine level\>or=2mg/dl(177umol/L) * anticipated life span \< 12 months * enrollment in other clinical trials at the same time not reaching the primary endpoint and probably interference the present trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cerebrovascular complications and Score of neurological defect | before treatment, after the first treatment, 7, 28days after treatment and follow up at 6 months after treatment |
Secondary
| Measure | Time frame |
|---|---|
| The S-100B and NSE blood level | before treatment, after the last treatment, before surgery, and the first 72 hours of surgery follow-up |
Countries
China
Outcome results
None listed